Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29202010.2217/fon-2019-07452-s2.0-85078816184https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31312Cancer ResearchOncologyCancer ResearchOncologyGermline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapyother